Total parenteral nutrition and enteral nutrition in diabetes

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 3, Issue 1, 2000, Pages 5-10

  Wright, John ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; MONOUNSATURATED FATTY ACID;

CARBOHYDRATE INTOLERANCE; CRITICAL ILLNESS; DIABETES MELLITUS; ENTERIC FEEDING; FAT INTAKE; GLUCOSE METABOLISM; HEMOSTASIS; INSULIN INFUSION; METABOLIC REGULATION; NUTRITIONAL SUPPORT; REVIEW; TOTAL PARENTERAL NUTRITION; VASCULAR DISEASE;

DIABETES MELLITUS; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY FIBER; ENTERAL NUTRITION; FATTY ACIDS, OMEGA-3; HUMANS; PARENTERAL NUTRITION, TOTAL;

EID: 0033929338     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-200001000-00002     Document Type: Review

References (48)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
2. UK Prospective Diabetes Study Group. Intensive blood glucose control with •• sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998; 352:837-853. This major study documented the benefits of glycaemic control on the development of microvascular complications in type 2 diabetes.
3. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996; 3:213-219.
4. Manninen V, Tenkanen L, Koskinen P, Mānttāri M, Heinonen OP, Frick MH. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentration on coronary heart disease risk in the Helsinki Heart Study: implications for treatment. Circulation 1992; 85:37-45.
5. Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, et al. • Gemfibrozil for the secondary prevention of CHD in men with low levels of high-density lipoprotein cholesterol. N Engl J Med 1999; 41:410-418. This paper provides long-awaited evidence that increasing high-density lipoprotein-cholesterol and reducing triglycerides levels (without changing low-density lipoprotein-cholesterol) results in a reduction in cardiovascular risk.
6. Schrezenmeir J. Rationale for specialized nutritional support for hyperglycemic patients. Clin Nutr 1998; 17 (Suppl 2):26-34.
7. Silk DBA. Enteral diet choices and formulations. In: Artificial nutrition support in clinical practice. Payne-James J, Grimble G, Silk DBA (editors). Edward Arnold; 1995. pp. 214-216.
8. Heilbronn LK, Noakes M, Clifton PM. Effect of energy restriction, weight loss • and diet composition on plasma lipids and glucose in patients with type 2 diabetes. Diabetes Care 1999; 22:889-895. This paper provides a demonstration that equicaloric high-fat and high-carbohydrate diets have similar results in terms of weight loss.
9. Anderson JW, Akanji AO. Dietary fibre: an overview. Diabetes Care 1991; 14:1126-1131.
10. Gardner CD, Kraemer HC. Monounsaturated versus polyunsaturated dietary fat and serum lipids: a meta-analysis. Arterioscler Thromb Vasc Biol 1995; 15:1917-1927.
11. Mensink RP, Katan MB. Effect of monounsaturated fatty acids versus complex carbohydrates on high-density lipoprotein in healthy men and women. Lancet 1987; i:122-124.
12. Garg A. High-MUFA diets for patients with DM: a meta-analysis. Am J Clin Nutr •• 1998; 67 (Suppl 3):577S-582S. This is an excellent meta-analysis of studies that compared high-fat and high-carbohydrate diets in the treatment of diabetes.
13. Toeller M, Klischan A, Heitkamp G, Schumacher W, Milne R, Buyken A, et al., and the EURODIAB IDDM Complications Study Group. Nutritional intake of 2668 IDDM patients from 30 centres in Europe. Diabetologia 1996, 39:929-939.
14. Kris-Etherton PM. Monounsaturated fatty acids and risk of cardiovascular disease. Circulation 1999, 100:1253-1258.
15. Yaqoob P, Knapper JA, Webb DH, Williams CM, Newsholme EA, Calder PC. Effect of olive oil on immune function in middle-aged men. Am J Clin Nutr 1998; 67:129-135.
16. Coulston AM. Clinical experience with modified enteral formulas for patients • with diabetes. Clin Nutr 1998; 17 (Suppl 2):46-56. A good review is provided of clinical studies of enteral diets of varying formulation in diabetes.
17. Peters A, Davidson MB, Isaac RM. Lack of glucose elevation after simulated tube feeding with a low-carbohydrate, high-fat enteral formula in patients with type I diabetes. Am J Med 1989; 87:178-182.
18. Peters A, Davidson MB. Effects of various enteral feeding products on postprandial blood glucose responses in patients with type I diabetes. J Parenter Enteral Nutr 1992; 16:69-74.
19. Harley JR, Pohl SL, Isaac RM. Low carbohydrate with fiber versus high-carbohydrate without fiber enteral formulas. Effect on blood glucose excursion in patients with type 2 diabetes [abstract]. Clin Res 1989; 37:141.
20. Sanz A, Albero R, Playan J. Comparison of a high-complex carbohydrate enteral formula with a monounsaturated formula in patients with type 2 diabetes treated with insulin or sulfonylurea [abstract]. J Parenter Enteral Nutr 1994; 18:31.
21. Low CC, Grossman EB, Gumbiner B. Potentiation of effects of weight loss by monounsaturated fatty acids in obese NIDDM patients. Diabetes 1996; 45:569-575.
22. Grahm TW, Harrington TR, Isaac RM. Low carbohydrate with fiber enteral formula impedes development of hyperglycemia in patients with acute head injury [abstract]. Clin Res 1989; 37:138.
23. Craig LD, Nicholson S, Silverstone FA, Kennedy RD. Use of a reduced-carbohydrate, modified-fat enteral formula for improving metabolic control and clinical outcomes in long-term care residents with type 2 diabetes: results of a pilot trial. Nutrition 1998; 14:529-534.
24. Riccardi G, Rivellese AA. Effects of dietary fiber and carbohydrate on glucose and lipoprotein metabolism in diabetic patients. Diabetes Care 1991; 14:1115-1125.
25. Jenkins DJA, Wolever TMS, Leeds AR, Gassull MA, Haisman P, Dilawari J, et al. Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity. Br Med J 1978; i:1392-1394.
26. Thomas BL, Laine DC, Goetz FC. Glucose and insulin response in diabetic subjects: acute effect of carbohydrate level and the addition of soy polysaccharide in defined-formula diets. Am J Clin Nutr 1988; 48:1048-1052.
27. Berry EM. Dietary fatty acids in the management of diabetes mellitus. Am J Clin Nutr 1997; 66 (Suppl 4):991S-917S.
28. Malasanos TH, Stacpoole FW. Biological effects of w-3 fatty acids in diabetes mellitus. Diabetes Care 1991; 14:1160-1179.
29. Hongsermeier T, Bistrian BR. Evaluation of a practical technique for determining insulin requirements in diabetic patients receiving total parenteral nutrition. J Parenter Enterai Nutr 1993; 17:16-19.
30. Wolfe RR. Sepsis as a modulator of adaptation to low and high carbohydrate • and low and high fat intakes. Eur J Clin Nutr 1999; 53 (Suppl 1):S136-S142. A good review is provided of carbohydrate metabolism in surgical stress, which is largely based on the author's extensive work.
31. Shangraw RE, Jahoor F, Miyoshi H, Neff WA, Stuart CA, Hemdon DN, Wolfe RR. Differentiation between septic and postburn insulin resistance. Metabolism 1989; 38:983-989.
32. Wolfe RR, Durkot MJ, Allsop JR, Burke JF. Glucose metabolism in severely burned patients. Metabolism 1979; 28:1031-1039.
33. McMahon M, Manji N, Driscoll DF, Bistrian BR. Parenteral nutrition in patients with diabetes mellitus: theoretical and practical considerations. J Parenter Enteral Nutr 1989; 13:545-553.
34. Woolfson AMJ, Heatley RV, Allison SP. Insulin to inhibit protein catabolism after injury. N Engl J Med 1979; 300:14-17.
35. Shizgal HM, Posner B. Insulin and the efficacy of parenteral nutrition. J Parenter Enteral Nutr 1989, 50:1355-1363.
36. MacFie J, Yule AG, Hill GL. Effect of added insulin on body composition of gastroenterologic patients receiving intravenous nutrition: a controlled clinical trial. Gastoenterology 1981; 81:285-289.
37. Jahoor F, Shangraw RE, Miyoshi H, Wallfish H, Hendon DN, Wolfe RR. Role of insulin and glucose oxidation in mediating the protein catabolism of burns and sepsis. Am J Physiol 1989; 257:E323-E331.
38. Sakurai Y, Aaarsland A, Herndon DN, Chinkes DL, Pierre E, Nguyen TT, et al. Stimulation of protein synthesis by long-term insulin infusion in severely burned patients. Ann Surg 1995; 222:283-294.
39. Alberti KGMM. Diabetes and surgery. Anesthesiology 1991; 74:209-211.
40. Hirsch IB, McGill JB, Cryer PE, White PF. Perioperative management of surgical patients with diabetes mellitus. Anesthesiology 1991; 74:346-359.
41. Krzywda EA, Andris DA, Whipple JK, Street CC, Ausman RK, Schulte WJ, Quebbman EJ. Glucose response to abrupt initiation and discontinuation of total parenteral nutrition. J Parenter Enteral Nutr 1993; 17:64-67.
42. Crowe PJ, Dennison AR, Royle GT. A new intravenous emulsion containing medium-chain triglyceride: studies of its metabolic effects in the postoperative period compared with conventional long-chain triglyceride emulsion. J Parenter Enterai Nutr 1985; 9:720-724.
43. Mingrone G, De Gaetano A, Greco AV, Capristo E, Benedetti G, Castagneto M, Gabarrini G. Dodecanoic acid infusion induces a sparing effect on whole-body glucose uptake, mainly in non-insulin-dependent diabetes mellitus. Br J Nutr 1997; 78:723-735.
44. Greco AV, Mingrone G, Capristo E, Benedetti G, DeGaetano S, Gasbarrini G. The metabolic fate of dodecanoic acid infusion in non-insulin-dependent diabetic patients. Nutrition 1998; 14:351-357.
45. Hjortrup A, Sorensen C, Dyremose E, Hjortso NC, Kehlet H. Influence of diabetes on operative risk. Br J Surg 1985; 72:783-785.
46. Pomposelli JJ, Baxter JK, Babineau TJ, Pomfret EA, Driscoll DF, Forse RA, Bistrian BR. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. J Parenter Enteral Nutr 1998; 22:77-81.
47. Overett TK, Bistrian BR, Lowry SF, Hopkins BS, Miller DM, Blackburn GL. Total parenteral nutrition in patients with insulin-requiring diabetes mellitus. J Am Coll Nutr 1986; 5:79-89.
48. McMahon MM, Rizza RA. Nutrition support in hospitalised patients with diabetes mellitus. Mayo Clinic Proc 1996; 71:587-594.